Assignee
ULTIMOVACS AS
NO5 patents
Top patents by PatentIndex Score
US10383928B2Aug 20, 2019
Telomerase polypeptide vaccine for treating cancer
ULTIMOVACS AS4 citations79
US12168045B2Dec 17, 2024
Vaccine in combination with an immune checkpoint inhibitor for use in treating cancer
ULTIMOVACS AS0 citations60
US11419927B2Aug 23, 2022
Vaccine in combination with an immune checkpoint inhibitor for use in treating cancer
ULTIMOVACS AS0 citations60
US11998595B2Jun 4, 2024
Telomerase polypeptide vaccine for treating cancer
ULTIMOVACS AS0 citations58
US11529403B2Dec 20, 2022
Telomerase polypeptide vaccine for treating cancer
ULTIMOVACS AS0 citations58